Table 2.
Adjusted Case Fatality | ||||
---|---|---|---|---|
Women | Men | HR (95% CI) | p Value | |
All | ||||
30 d | 16.0% | 19.0% | <.0001 | |
1 y | 27.7% | 32.4% | 0.83 (0.80–0.86) | <.0001 |
Year 2005–2009 | ||||
30 d | 17.3% | 20.4% | <.0001 | |
1 y | 30.2% | 34.6% | 0.85 (0.81–0.89) | <.0001 |
Year 2010–2014 | ||||
30 d | 14.6% | 17.3% | <.0001 | |
1 y | 25.0% | 29.9% | 0.81 (0.77–0.86) | <.0001 |
Age 70–79 y | ||||
30 d | 9.4% | 12.4% | <.0001 | |
1 y | 17.1% | 21.1% | 0.79 (0.74–0.85) | <.0001 |
Age ≥ 80 y | ||||
30 d | 22.2% | 25.3% | <.0001 | |
1 y | 37.8% | 43.2% | 0.84 (0.81–0.88) | <.0001 |
ST elevation MI | ||||
30 d | 19.6% | 21.7% | .018 | |
1 y | 28.2% | 31.0% | 0.90 (0.84–0.96) | .001 |
Non-ST elevation MI | ||||
30 d | 14.3% | 17.8% | <.0001 | |
1 y | 27.5% | 33.0% | 0.80 (0.77–0.83) | <.0001 |
Revascularized | ||||
30 d | 6.1% | 7.0% | .072 | |
1 y | 10.6% | 12.5% | 0.84 (0.76–0.93) | .0005 |
Non-revascularized | ||||
30 d | 21.4% | 25.8% | <.0001 | |
1 y | 37.3% | 43.7% | 0.82 (0.79–0.85) | <.0001 |
Atrial fibrillation | ||||
30 d | 19.2% | 22.4% | .001 | |
1 y | 36.6% | 41.1% | 0.86 (0.81–0.92) | <.0001 |
No atrial fibrillation | ||||
30 d | 14.9% | 17.9% | <.0001 | |
1 y | 25.0% | 29.7% | 0.82 (0.78–0.86) | <.0001 |
Diabetes | ||||
30 d | 18.9% | 20.7% | .043 | |
1 y | 33.5% | 36.3% | 0.91 (0.85–0.96) | .002 |
No diabetes | ||||
30 d | 14.9% | 18.3% | <.0001 | |
1 y | 25.6% | 30.8% | 0.80 (0.77–0.84) | <.0001 |
Note: HR = hazard ratio within 1-y follow-up; MI = myocardial infarction.